Townsquare Capital LLC Invitae Corp Transaction History

Townsquare Capital LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 15, 2024	SELL	$0.42 - $0.72 $3,487 - $5,978	-8,304 Reduced 29.59%	19,759 $12,000
Q3 2023 Nov 15, 2023	SELL	$0.6 - $1.53 $178 - $454	-297 Reduced 1.05%	28,063 $16,000
Q2 2023 Nov 13, 2023	SELL	$1.05 - $1.63 $966 - $1,499	-920 Reduced 3.14%	28,360 $32,000
Q1 2023 May 11, 2023	BUY	$1.2 - $2.73 $16,255 - $36,980	13,546 Added 86.09%	29,280 $39,000
Q4 2022 Feb 13, 2023	SELL	$1.71 - $3.61 $29,889 - $63,099	-17,479 Reduced 52.63%	15,734 $29,000
Q3 2022 Nov 10, 2022	BUY	$1.9 - $8.63 $41,053 - $186,468	21,607 Added 186.17%	33,213 $82,000
Q2 2022 Aug 08, 2022	SELL	$2.13 - $9.01 $27,653 - $116,976	-12,983 Reduced 52.8%	11,606 $28,000
Q1 2022 Apr 28, 2022	BUY	$6.28 - $15.59 $90,099 - $223,669	14,347 Added 140.08%	24,589 $196,000
Q4 2021 Feb 11, 2022	BUY	$14.7 - $28.67 $150,557 - $293,638	10,242 New	10,242 $156,000

2.12M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Townsquare Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Townsquare Capital LLC with notifications on news.